Figure 1
Figure 1. Autophagy is induced during macrophagic differentiation of human monocytes. Human peripheral blood monocytes from healthy donors were exposed for the indicated times to 100 ng/mL CSF-1. (A) Electron microscopy images showing ultrastructural features of a representative monocyte (d0) and morphologic features of autophagy in monocytes treated for 3 days (d3) with CSF-1. P indicates phagophore; A, autophagosome; and N, nuclei. (B) Immunoblot analysis of caspase-3, NPM, LC3, Lamp2, CTSB, and SQSTM1 in monocytes exposed for the indicated times to CSF-1. Actin is used as a loading control. *Cleavage fragments. Molecular weights (MW) are in kDa. (C) Measurement of CTSB and B + L activities using Z-RR-AMC or Z-FR-AMC as substrates, respectively, in monocytes treated with CSF-1. Results, expressed as arbitrary units (A.U.) per minute and per milligram of protein, are the mean ± SD of 4 independent experiments performed in quadruplicate. (D) Monocytes were exposed for 3 days to 100 ng/mL alone or in association with bafilomycin A1 (10nM) added 48 hours after CSF-1 treatment, and protein expression was analyzed by immunoblot. Actin is used as a loading control. (E) Monocytes were exposed for 2 days to CSF-1 before collecting cytoplasmic (F1) and microsomal (F2) extracts that were analyzed by immunoblot. Lamp2 and γ-tubulin are used as a control for microsomal and cytoplasmic fractions, respectively. (F) Immunoblot analysis of phospho-ULK1 (Ser555) and ULK1 in monocytes exposed for the indicated times to CSF-1. (G) Monocytes were transfected with siRNA targeting Luciferase (Luc) or ULK1 and exposed 2 days to CSF-1. The expression of ULK1 in transfected cells was analyzed by immunoblot. (F-G) Actin is used as a loading control. (H) Monocytes were transfected with siRNA targeting Luciferase (Luc) or ULK1 and exposed 2 days to CSF-1. Macrophage differentiation was examined morphologically (fibroblastic shape) and by 2-color flow cytometric analysis. Percentages indicate cells that express both CD71 and CD163.

Autophagy is induced during macrophagic differentiation of human monocytes. Human peripheral blood monocytes from healthy donors were exposed for the indicated times to 100 ng/mL CSF-1. (A) Electron microscopy images showing ultrastructural features of a representative monocyte (d0) and morphologic features of autophagy in monocytes treated for 3 days (d3) with CSF-1. P indicates phagophore; A, autophagosome; and N, nuclei. (B) Immunoblot analysis of caspase-3, NPM, LC3, Lamp2, CTSB, and SQSTM1 in monocytes exposed for the indicated times to CSF-1. Actin is used as a loading control. *Cleavage fragments. Molecular weights (MW) are in kDa. (C) Measurement of CTSB and B + L activities using Z-RR-AMC or Z-FR-AMC as substrates, respectively, in monocytes treated with CSF-1. Results, expressed as arbitrary units (A.U.) per minute and per milligram of protein, are the mean ± SD of 4 independent experiments performed in quadruplicate. (D) Monocytes were exposed for 3 days to 100 ng/mL alone or in association with bafilomycin A1 (10nM) added 48 hours after CSF-1 treatment, and protein expression was analyzed by immunoblot. Actin is used as a loading control. (E) Monocytes were exposed for 2 days to CSF-1 before collecting cytoplasmic (F1) and microsomal (F2) extracts that were analyzed by immunoblot. Lamp2 and γ-tubulin are used as a control for microsomal and cytoplasmic fractions, respectively. (F) Immunoblot analysis of phospho-ULK1 (Ser555) and ULK1 in monocytes exposed for the indicated times to CSF-1. (G) Monocytes were transfected with siRNA targeting Luciferase (Luc) or ULK1 and exposed 2 days to CSF-1. The expression of ULK1 in transfected cells was analyzed by immunoblot. (F-G) Actin is used as a loading control. (H) Monocytes were transfected with siRNA targeting Luciferase (Luc) or ULK1 and exposed 2 days to CSF-1. Macrophage differentiation was examined morphologically (fibroblastic shape) and by 2-color flow cytometric analysis. Percentages indicate cells that express both CD71 and CD163.

Close Modal

or Create an Account

Close Modal
Close Modal